Aspergillus Sensitization or Carriage in Cystic Fibrosis Patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  2014-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/INF.0000000000000231PMID 24336095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allergic bronchopulmonary aspergillosis in children

  2015cited by this paper
• Role of long term antibiotics in chronic respiratory diseases.

  2013cited by this paper
• Novel immunologic classification of aspergillosis in adult cystic fibrosis.

  2013cited by this paper
• IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis.

  2013cited by this paper
• Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients

  2012influential reference
• Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.

  2012cited by this paper
• Open‐label, follow‐on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa

  2012cited by this paper
• Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa: A Randomized Controlled Trial

  2012cited by this paper
• Risk Factors for Aspergillus Colonization and Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis

  2010cited by this paper
• The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.

  2010cited by this paper
• Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.

  2010cited by this paper
• Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi.

  2010cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.

  2009cited by this paper
• Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

  2009cited by this paper
• Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis.

  2009cited by this paper
• Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

  2008cited by this paper
• Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

  2008cited by this paper
• Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

  2007cited by this paper
• Évolution des épreuves fonctionnelles respiratoires (EFR) chez des enfants atteints de mucoviscidose et dépistés à la naissance. Lien avec l'infection pulmonaire. Étude sur 40 enfants et 744 EFR

  2007cited by this paper
• Computational methods for case-cohort studies

  2007cited by this paper
• [Longitudinal evaluation of pulmonary function tests in children with newborn screening for cystic fibrosis. Relationships with pulmonary infection. Study of 40 children undergoing 744 pulmonary function tests].

  2007cited by this paper
• Aspergillus bronchitis in cystic fibrosis.

  2006cited by this paper
• Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis

  2006cited by this paper
• Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis

  2006cited by this paper
• Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial

  2006cited by this paper
• Genotype-phenotype correlation for pulmonary function in cystic fibrosis

  2005cited by this paper
• Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.

  2005cited by this paper
• Cystic fibrosis adult care: consensus conference report.

  2004cited by this paper
• Identification of common Aspergillus species

  2003cited by this paper
• Pathophysiology and management of pulmonary infections in cystic fibrosis.

  2003cited by this paper
• Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

  2003cited by this paper
• Genetics of idiopathic disseminated bronchiectasis.

  2003cited by this paper
• The Phenotypic Consequences of CFTR Mutations

  2003cited by this paper
• Catalases of Aspergillus fumigatus

  2003cited by this paper
• Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference.

  2003cited by this paper
• Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.

  2003cited by this paper
• Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis

  2003cited by this paper
• Serologic IgE immune responses against Aspergillus fumigatus and Candida albicans in patients with cystic fibrosis.

  2002cited by this paper
• Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis?

  2002cited by this paper
• Allergic bronchopulmonary aspergillosis.

  2002cited by this paper
• Allergic bronchopulmonary aspergillosis in cystic fibrosis.

  2001cited by this paper
• Establishing a standard definition for child overweight and obesity worldwide: international survey

  2000cited by this paper
• Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

  2000cited by this paper
• Genotype and Phenotype in Cystic Fibrosis

  2000cited by this paper
• Aspergillose bronchopulmonaire allergique chez l'enfant

  1999cited by this paper
• [Allergic bronchopulmonary aspergillosis in children].

  1999cited by this paper
• Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients.

  1999cited by this paper
• Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus

  1997cited by this paper
• Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis.

  1996cited by this paper
• [Allergic bronchopulmonary aspergillosis].

  1996cited by this paper
• Evaluation de l'immunoélectrophorèse rapide Paragon® (Beckman) appliquée au sérodiagnostic aspergillaire

  1994cited by this paper
• Pulmonary function between 6 and 18 years of age

  1993cited by this paper
• Body Mass Index variations: centiles from birth to 87 years.

  1991cited by this paper
• Allergic bronchopulmonary aspergillosis in cystic fibrosis.

  1984cited by this paper
• Etude comparee sur immunoelectrophoregramme des enzymes de l'extrait antigenique d'aspergillus fumigatus, reveles par des serums experimentaux et des serums de malades atteints d'aspergillose

  1969cited by this paper
• [Comparative study on immunoelectrophoregrams of enzymes of the antigenic extract of Aspergillus fumigatus revealed by experimental serums and serums of patients with aspergillosis].

  1969cited by this paper
• A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

  1959cited by this paper

• How Should IgG Seroconversion to Aspergillus fumigatus be Interpreted in Children With Cystic Fibrosis

  2026cites this paper
• Exploring the Epidemiology and Clinico-Demographic Characteristics of Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis

  2023cites this paper
• First Aspergillus fumigatus IgG seroconversion is associated with more severe disease in CF children

  2023cites this paper
• Frequencies of pathogenic CFTR variants in Greek cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus fumigatus chronic colonization: A retrospective cohort study.

  2022cites this paper
• CF Fungal Disease in the Age of CFTR Modulators

  2021cites this paper
• The utility of the basophil activation test in differentiating asthmatic subjects with and without allergic bronchopulmonary aspergillosis

  2020cites this paper
• Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis

  2020cites this paper
• Fungal Infections and ABPA

  2020cites this paper
• Taking a look on fungi in cystic fibrosis: More questions than answers.

  2020cites this paper
• Aspergillus colonization and antifungal immunity in cystic fibrosis patients.

  2019cites this paper
• Title Aspergillus Species in Bronchiectasis : Challenges in theCystic Fibrosis and Non-cystic Fibrosis Airways

  2019cites this paper
• Prevalence of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Patients using Two Different Diagnostic Criteria.

  2019influential citation
• Prospective evaluation of a new Aspergillus IgG EIA kit for the diagnosis of chronic and allergic pulmonary aspergillosis

  2019cites this paper
• Aspergillus fumigatus in cystic fibrosis: An update on immune interactions and molecular diagnostics in allergic bronchopulmonary aspergillosis

  2017cites this paper
• Aspergillus fumigatus in cystic fibrosis : an update on immune interactions and molecular diagnostics in ABPA Running title : Immune interactions and molecular diagnostics in ABPA

  2017cites this paper
• Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

  2017cites this paper
• Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways

  2017cites this paper
• Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis

  2017cites this paper
• Multivariate Analysis As a Support for Diagnostic Flowcharts in Allergic Bronchopulmonary Aspergillosis: A Proof-of-Concept Study

  2017cites this paper
• Challenges in Laboratory Detection of Fungal Pathogens in the Airways of Cystic Fibrosis Patients

  2017cites this paper
• Prospective Evaluation of a New Aspergillus IgG Enzyme Immunoassay Kit for Diagnosis of Chronic and Allergic Pulmonary Aspergillosis

  2016cites this paper
• Aspergillus infections in cystic fibrosis.

  2016cites this paper
• The role of basophil activation test in allergic bronchopulmonary aspergillosis and Aspergillus fumigatus sensitization in cystic fibrosis patients.

  2016cites this paper
• Omalizumab as New Modality of Treatment ABPA in Cystic Fibrosis Patient: Case Report

  2016cites this paper
• Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions.

  2016cites this paper
• Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta‐analysis

  2015cites this paper
• Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship

  2015cites this paper
• Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma

  2015cites this paper
• [Indoor fungal exposure: What impact on clinical and biological status regarding Aspergillus during cystic fibrosis].

  2015cites this paper
• Fungal Culture and Sensitisation in Asthma, Cystic Fibrosis and Chronic Obstructive Pulmonary Disorder: What Does It Tell Us?

  2014cites this paper
• Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

  2014cites this paper
• Evaluation of the Aspergillus Western Blot IgG Kit for Diagnosis of Chronic Aspergillosis

  2014cites this paper
• Fungi in the cystic fibrosis lung: bystanders or pathogens?

  2014cites this paper
• Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.

  2014cites this paper